Therapy-Related Myelodysplastic Syndrome Active Not Recruiting Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02658487Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid LeukemiaTreatment